HAWKHILL THERAPEUTICS Ltd
through Sep 29, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Jun 23, 2026 · D | Sep 29, 2026 · D/A | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $192,569 | $290,530 | $97,961 |
| Reported amount sold | $192,569 | $290,530 | $97,961 |
| Reported investor count | 1 | 1 | 0 |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0002140690-26-000001 · Later SEC source: 0002140690-26-000002
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $290,530
- Reported amount sold
- $290,530
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Contact info
Log in to look up an email or website for this issuer.
Form D filings (2)
-
0002140690-26-000002D/A · Sep 29, 2026 · BiotechnologyOffering: $290,530Sold: $290,530
-
0002140690-26-000001D · Jun 23, 2026 · BiotechnologyOffering: $192,569Sold: $192,569